-
lung cancer research: 9 Essential Findings Changing How Evidence Is Evaluated (2026)
By Northern Peptides Staff | October 28, 2026 What has rigorous research established about lung cancer? lung cancer research has shown, in selected high-risk populations, that low-dose CT screening can reduce deaths from lung cancer; it has also demonstrated that tumour biology can identify groups with different responses in randomized clinical trials. In the National…
-
Alzheimers Disease Research: 9 Essential Breakthroughs and Evidence Limits (2026)
By Northern Peptides Staff | October 27, 2026 What has Alzheimer’s research established, and what remains uncertain? Scientists can now measure several disease-associated biological changes, including amyloid and tau abnormalities, and randomized trials have demonstrated modest slowing of clinical decline in selected people with early symptomatic disease. In the 2023 New England Journal of Medicine…
-
Stroke Prevention Research: 9 Essential Findings From Landmark Studies (2026)
By Northern Peptides Staff | October 26, 2026 What has stroke prevention research demonstrated most clearly? Blood-pressure-related vascular injury is a major, modifiable contributor to stroke risk, and controlled trials show that reducing blood pressure in defined study populations can reduce stroke events. In the randomized SHEP trial reported in JAMA in 1991, 4,736 older…
-
psoriasis research: 7 Powerful Insights Into Inflammation (2026)
Current psoriasis research identifies the IL-23–IL-17 signalling pathway and its interaction with epidermal keratinocytes as central features of plaque psoriasis, while randomized studies show that precisely targeted biologic mechanisms can change measured skin-disease outcomes. A 2021 Lancet review of therapies targeting this pathway describes abnormal keratinocyte proliferation and differentiation driven by inflammatory signals. These findings…
-
Brain Tumor Biomarker Research: 7 Powerful, Remarkable Discoveries (2026)
Brain tumor biomarker research has transformed how scientists classify central nervous system tumours. The World Health Organization’s modern classification incorporates molecular information alongside tissue appearance. Markers including IDH mutations, 1p/19q codeletion and MGMT promoter methylation provide biologically important information, although they serve different diagnostic, prognostic and predictive purposes. The US National Cancer Institute documents how…
-
amyloidosis research: 7 Important Breakthroughs and Hard Lessons (2026)
Amyloidosis research shows that several distinct diseases arise when normally soluble proteins misfold, assemble into amyloid fibrils and accumulate in tissues, while the best-supported scientific advances involve identifying the specific precursor protein and detecting affected organs earlier. In a pivotal 2016 Circulation study, Gillmore and colleagues demonstrated that carefully interpreted bone-scintigraphy findings, combined with the…
-
stuttering neuroscience research: 7 Powerful Brain-Imaging Insights (2026)
Stuttering neuroscience research shows reproducible group-level differences in the brain networks that coordinate speech movement, auditory feedback and timing, particularly in left-hemisphere speech pathways, but no single brain scan can diagnose stuttering or predict an individual’s future. In a primary diffusion-MRI study published in Brain in 2015, Chang, Zhu, Choo and Angstadt compared 37 children…
-
Iodine Deficiency and Thyroid Hormone Research: Biomarkers, Brain Development & Emerging Science
Iodine is a trace element with an outsized influence on human development. The body needs it for one principal purpose: building the thyroid hormones thyroxine (T4) and triiodothyronine (T3), which regulate metabolism, growth and — most critically — brain development before birth and in early childhood. When iodine intake falls short, hormone production falters, and…
-
Osteoporosis Bone Turnover Biomarkers: 7 Key Findings
Bone is not a static mineral deposit. Throughout life, specialized cells continuously remove older bone and replace it with new tissue, and when the balance between those processes shifts too far, bone density falls and fracture risk rises. Osteoporosis develops when resorption exceeds formation for long enough — sometimes over years — that skeletal strength…
-
Pediatric Bone and Joint Research: 7 Major Advances
Childhood is not a passive period of skeletal growth. During infancy, childhood and adolescence, bones lengthen, widen, mineralize and remodel while joints develop the cartilage, ligaments and lubricating systems required for a lifetime of movement. The same biological processes that build a resilient skeleton can also produce growth disorders, fragile bones, joint damage and chronic…